X-linked endothelial corneal dystrophy

From WikiMD.com Medical Encyclopedia

A rare genetic disorder affecting the cornea


Template:Medical condition (new)

X-linked endothelial corneal dystrophy (XECD) is a rare genetic disorder that affects the cornea, the transparent front part of the eye. This condition is characterized by abnormalities in the endothelium, the innermost layer of the cornea, leading to corneal edema and vision impairment.

Pathophysiology[edit | edit source]

The corneal endothelium is responsible for maintaining corneal transparency by regulating fluid and solute transport between the aqueous humor and the stroma. In X-linked endothelial corneal dystrophy, mutations in the genes responsible for endothelial cell function lead to dysfunction and degeneration of these cells. This results in an imbalance of fluid regulation, causing corneal swelling and loss of transparency.

Genetics[edit | edit source]

XECD is inherited in an X-linked recessive pattern, meaning the defective gene is located on the X chromosome. Males, having only one X chromosome, are more severely affected, while females, with two X chromosomes, may be carriers and exhibit milder symptoms. The specific gene mutations associated with XECD have been identified in some cases, but the genetic basis of the disorder is not fully understood.

Clinical Features[edit | edit source]

Individuals with X-linked endothelial corneal dystrophy typically present with symptoms in early childhood. Common clinical features include:

The severity of symptoms can vary, with some individuals experiencing significant vision impairment, while others may have only mild symptoms.

Diagnosis[edit | edit source]

Diagnosis of XECD is based on clinical examination and family history. Slit-lamp examination can reveal characteristic changes in the corneal endothelium. Genetic testing may be used to confirm the diagnosis by identifying mutations in the relevant genes.

Management[edit | edit source]

There is currently no cure for X-linked endothelial corneal dystrophy. Management focuses on alleviating symptoms and preserving vision. Treatment options may include:

Regular monitoring by an ophthalmologist is essential to manage the condition effectively.

Prognosis[edit | edit source]

The prognosis for individuals with XECD varies depending on the severity of the condition. Early diagnosis and appropriate management can help maintain vision and improve quality of life.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD